Citation Impact

Citing Papers

Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
2014
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Epithelial Regeneration After Gastric Ulceration Causes Prolonged Cell-Type Alterations
2016
Gastric cancer
2016 Standout
Endoscopic submucosal dissectionvsendoscopic mucosal resection for early gastric cancer: A meta-analysis
2014
Engineering precision nanoparticles for drug delivery
2020 Standout
Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
2013
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Prospective, Controlled Tandem Endoscopy Study of Narrow Band Imaging for Dysplasia Detection in Barrett's Esophagus
2008
Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists
2019
Multifocal Neoplasia and Nodal Metastases in T1 Esophageal Carcinoma
2008
American Gastroenterological Association Technical Review on the Role of the Gastroenterologist in the Management of Esophageal Carcinoma
2005
Pyroptosis: mechanisms and diseases
2021 Standout
Oesophageal carcinoma
2013 Standout
Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial
2019
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Gastric cancer
2020 Standout
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma
2006
Narrow band imaging directed EMR for Barrett's esophagus with high-grade dysplasia
2006
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
2015
VEGF-VEGFR Signals in Health and Disease
2014
Tissue Engineering Based on Cell Sheet Technology
2007
Transferrin-Conjugated Docetaxel–PLGA Nanoparticles for Tumor Targeting: Influence on MCF-7 Cell Cycle
2019
Chemotherapy for advanced gastric cancer
2017 Standout
Role of photodynamic therapy in the treatment of esophageal cancer
2019
History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer
2019

Works of Chikatoshi Katada being referenced

Prognostic Advantage of Docetaxel/Cisplatin/ 5-Fluorouracil Neoadjuvant Chemotherapy in Clinical Stage II/III Esophageal Squamous Cell Carcinoma due to Excellent Control of Preoperative Disease and Postoperative Lymph Node Recurrence
2017
NSAID, aspirin delays gastric ulcer healing with reduced accumulation of CXCR4+VEGFR1+ cells to the ulcer granulation tissues
2013
Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions
2003
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection
2017
Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort study
2007
Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a retrospective comparison with conventional endoscopic resection in a single center
2013
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)
2011
A Multicenter, Phase I Dose-Escalating Study of Docetaxel, Cisplatin and S-1 for Advanced Gastric Cancer (KDOG0601)
2008
Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites
2004
Narrow Band Imaging: A New Diagnostic Approach to Visualize Angiogenesis in Superficial Neoplasia
2005
[Clinical development of S-1 (TS-1) for advanced gastric cancer].
2006
Local recurrence of squamous-cell carcinoma of the esophagus after EMR
2005
Final analysis of single-arm confirmatory study of diagnostic endoscopic resection(ER) plus selective chemoradiotherapy (CRT) for stage I esophageal squamous cell carcinoma (ESCC): JCOG0508.
2018
Rankless by CCL
2026